Cardinal Health, Inc. $CAH Stock: Danske Bank A S Grows Position

Danske Bank A S grew its position in Cardinal Health, Inc. (NYSE:CAH – Free Report) by 5.4% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 160,269 shares of the company’s stock after purchasing an additional 8,247 shares during the period. Danske Bank A S owned approximately 0.07% of Cardinal Health worth $35,660,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of CAH. BlackRock Inc. acquired a new position in Cardinal Health during the second quarter valued at approximately $6,293,115,000. Wellington Management Group LLP grew its stake in Cardinal Health by 247.5% during the second quarter. Wellington Management Group LLP now owns 14,860,271 shares of the company’s stock worth $3,530,206,000 after buying an additional 10,584,119 shares during the period. Bank of America Corp DE acquired a new stake in shares of Cardinal Health in the second quarter worth $689,066,000. Legal & General Group Plc acquired a new stake in shares of Cardinal Health in the second quarter worth $438,870,000. Finally, Pacer Advisors Inc. increased its position in shares of Cardinal Health by 14.7% in the first quarter. Pacer Advisors Inc. now owns 1,565,131 shares of the company’s stock worth $330,728,000 after acquiring an additional 200,021 shares in the last quarter. Hedge funds and other institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Up 1.0%

Shares of CAH stock opened at $283.95 on Tuesday. The firm has a fifty day simple moving average of $244.90 and a 200-day simple moving average of $225.61. The company has a market capitalization of $65.63 billion, a PE ratio of 36.73, a price-to-earnings-growth ratio of 2.13 and a beta of 0.53. Cardinal Health, Inc. has a twelve month low of $180.45 and a twelve month high of $286.29.

Cardinal Health (NYSE:CAH – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported $3.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.94 by $0.32. The firm had revenue of $67.51 billion for the quarter, compared to the consensus estimate of $66.67 billion. Cardinal Health had a net margin of 0.71% and a negative return on equity of 102.72%. The firm’s quarterly revenue was up 5.5% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.55 EPS. Equities research analysts predict that Cardinal Health, Inc. will post 12.97 EPS for the current year.

Cardinal Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 15th. Investors of record on Monday, January 4th will be issued a $0.5158 dividend. The ex-dividend date of this dividend is Monday, January 4th. This represents a $2.06 dividend on an annualized basis and a yield of 0.7%. Cardinal Health’s dividend payout ratio is currently 26.65%.

Analysts Set New Price Targets

Several equities analysts recently weighed in on the stock. Citigroup lifted their target price on shares of Cardinal Health from $265.00 to $280.00 and gave the company a “buy” rating in a report on Wednesday, August 12th. Weiss Ratings raised shares of Cardinal Health from a “buy (b+)” rating to a “buy (a-)” rating in a research report on Monday, November 9th. Evercore reiterated an “outperform” rating and issued a $270.00 price target on shares of Cardinal Health in a report on Wednesday, August 12th. Robert W. Baird raised their price objective on Cardinal Health from $251.00 to $274.00 and gave the company an “outperform” rating in a research report on Wednesday, August 12th. Finally, Wells Fargo & Company boosted their price objective on Cardinal Health from $245.00 to $277.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 12th. One investment analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus price target of $279.44.

Get Our Latest Report on CAH

Insider Buying and Selling

In other Cardinal Health news, CEO Jason M. Hollar sold 44,529 shares of the company’s stock in a transaction that occurred on Wednesday, August 19th. The stock was sold at an average price of $236.18, for a total value of $10,516,859.22. Following the transaction, the chief executive officer directly owned 190,603 shares of the company’s stock, valued at $45,016,616.54. This represents a 18.94% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CAO Mary C. Scherer sold 2,302 shares of the stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $237.39, for a total value of $546,471.78. Following the transaction, the chief accounting officer owned 2,811 shares of the company’s stock, valued at approximately $667,303.29. This trade represents a 45.02% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. 0.12% of the stock is owned by company insiders.

Cardinal Health Profile

(Free Report)

Cardinal Health is a healthcare services and products company that distributes pharmaceuticals and medical supplies. Its customers include pharmacies, hospitals, surgery centers, physician offices and other healthcare providers. The company’s businesses include pharmaceutical distribution and specialty services, as well as the sourcing and distribution of medical and surgical products. Its offerings support areas such as specialty medications, medication management and supply-chain operations. Cardinal Health traces its roots to a wholesale business founded in Ohio in 1971 and later expanded into pharmaceutical distribution.

Featured Stories

Want to see what other hedge funds are holding CAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cardinal Health, Inc. (NYSE:CAH – Free Report).

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.